273 related articles for article (PubMed ID: 28385088)
21. The medicinal plants in the control of tuberculosis: Laboratory study on medicinal plants from the Northern Area of Pakistan.
Ullah S; Hussain S; Khan SN; Khurram M; Khan I; Khan MA
Int J Mycobacteriol; 2017; 6(1):102-105. PubMed ID: 28317814
[TBL] [Abstract][Full Text] [Related]
22. Infection caused by Mycobacterium tuberculosis.
Peloquin CA; Berning SE
Ann Pharmacother; 1994 Jan; 28(1):72-84. PubMed ID: 8123968
[TBL] [Abstract][Full Text] [Related]
23. Pasakbumin A controls the growth of Mycobacterium tuberculosis by enhancing the autophagy and production of antibacterial mediators in mouse macrophages.
Lee HJ; Ko HJ; Kim SH; Jung YJ
PLoS One; 2019; 14(3):e0199799. PubMed ID: 30865638
[TBL] [Abstract][Full Text] [Related]
24. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
Rose PC; Hallbauer UM; Seddon JA; Hesseling AC; Schaaf HS
Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
[TBL] [Abstract][Full Text] [Related]
25. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
[TBL] [Abstract][Full Text] [Related]
26. Ursolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatment.
Jiménez-Arellanes A; Luna-Herrera J; Cornejo-Garrido J; López-García S; Castro-Mussot ME; Meckes-Fischer M; Mata-Espinosa D; Marquina B; Torres J; Hernández-Pando R
BMC Complement Altern Med; 2013 Oct; 13():258. PubMed ID: 24098949
[TBL] [Abstract][Full Text] [Related]
27. Major genotype families and epidemic clones of Mycobacterium tuberculosis in Omsk region, Western Siberia, Russia, marked by a high burden of tuberculosis-HIV coinfection.
Pasechnik O; Vyazovaya A; Vitriv S; Tatarintseva M; Blokh A; Stasenko V; Mokrousov I
Tuberculosis (Edinb); 2018 Jan; 108():163-168. PubMed ID: 29523319
[TBL] [Abstract][Full Text] [Related]
28. Plants and fungal products with activity against tuberculosis.
De Souza MV
ScientificWorldJournal; 2005 Aug; 5():609-28. PubMed ID: 16113939
[TBL] [Abstract][Full Text] [Related]
29. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
30. Therapy Of XDR TB with thioridazine a drug beyond patent protection but eligible for patent "as new use".
Amaral L; Molnar J
Recent Pat Antiinfect Drug Discov; 2010 Jun; 5(2):109-14. PubMed ID: 20156179
[TBL] [Abstract][Full Text] [Related]
31. Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa.
Hanrahan CF; Selibas K; Deery CB; Dansey H; Clouse K; Bassett J; Scott L; Stevens W; Sanne I; Van Rie A
PLoS One; 2013; 8(6):e65421. PubMed ID: 23762367
[TBL] [Abstract][Full Text] [Related]
32. Drug resistance profiles of new- and previously treated patients with pulmonary tuberculosis in Ibadan, Nigeria.
Kehinde AO; Adebiyi EO; Salako AO; Ogunleye VO; Oni AA; Bakare RA; Eltayeb O; Dairo G; Out J; Gehre F; Corrah T; Deun AV; Gumusoboga M; Declercq E; Demeulenaere T; deJong BC; Antonio M
Afr J Med Med Sci; 2016 May; 45(1):67-73. PubMed ID: 28686829
[TBL] [Abstract][Full Text] [Related]
33. In Vitro Anti-mycobacterial Activity of Three Medicinal Plants of Lamiaceae Family.
Kazemian H; Heidari H; Yamchi JK; Zandi H; Taji A; Yazdani F; Hamzehloo G; Ghanavati R; Rahdar HA; Feizabadi MM
Recent Pat Antiinfect Drug Discov; 2018; 13(3):240-245. PubMed ID: 29952265
[TBL] [Abstract][Full Text] [Related]
34. In vitro anti-mycobacterial activity of selected medicinal plants against Mycobacterium tuberculosis and Mycobacterium bovis strains.
Gemechu A; Giday M; Worku A; Ameni G
BMC Complement Altern Med; 2013 Oct; 13():291. PubMed ID: 24168665
[TBL] [Abstract][Full Text] [Related]
35. Is Multi-Drug Resistant Tuberculosis More Prevalent in HIV-Infected Patients in Korea?
Lee S; Lee SH; Mok JH; Lee SJ; Kim KH; Lee JE; Lee SG; Chung JS; Kwak IS
Yonsei Med J; 2016 Nov; 57(6):1508-10. PubMed ID: 27593882
[TBL] [Abstract][Full Text] [Related]
36. Drug resistance characteristics and cluster analysis of M. tuberculosis in Chinese patients with multiple episodes of anti-tuberculosis treatment.
Hu Y; Zhao Q; Werngren J; Hoffner S; Diwan VK; Xu B
BMC Infect Dis; 2016 Jan; 16():4. PubMed ID: 26739444
[TBL] [Abstract][Full Text] [Related]
37. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
[TBL] [Abstract][Full Text] [Related]
38. Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.
Lee M; Mok J; Kim DK; Shim TS; Koh WJ; Jeon D; Lee T; Lee SH; Kim JS; Park JS; Lee JY; Kim SY; Lee JH; Jo KW; Jhun BW; Kang YA; Ahn JH; Kim CK; Shin S; Song T; Shin SJ; Kim YR; Ahn H; Hahn S; Won HJ; Jang JY; Cho SN; Yim JJ
Trials; 2019 Jan; 20(1):57. PubMed ID: 30651149
[TBL] [Abstract][Full Text] [Related]
39. Genotypes and drug susceptibility of Mycobacterium tuberculosis Isolates in Shihezi, Xinjiang Province, China.
Zhang J; Mi L; Wang Y; Liu P; Liang H; Huang Y; Lv B; Yuan L
BMC Res Notes; 2012 Jun; 5():309. PubMed ID: 22713520
[TBL] [Abstract][Full Text] [Related]
40. Antimycobacterial screening of selected medicinal plants against
Jethva KD; Bhatt DR; Zaveri MN
Int J Mycobacteriol; 2020; 9(2):150-155. PubMed ID: 32474536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
